Search

Author/Creator Frontzek, Fabian

1. A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. (1st April 2022)

Authors:
Hess, Georg; Hüttmann, Andreas; Witzens‐Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias; Lenz, Georg
Journal:
British journal of haematology
Issue:
Volume 198:Number 3(2022)
Page Start:
482
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cytokeratin expression in plasmablastic lymphoma – a possible diagnostic pitfall in the routine work‐up of tumours. Issue 6 (25th December 2020)

Authors:
Huettl, Katrin S; Staiger, Annette M; Horn, Heike; Frontzek, Fabian; Goodlad, John R; Tapia, Gustavo; Rosenwald, Andreas; Klapper, Wolfram; Fend, Falko; Climent, Fina; Castellvi, Josep; Tzankov, Alexandar; Dirnhofer, Stefan; Baptista, Maria João; Navarro, José‐Tomas; Anagnostopoulos, Ioannis; Har...
Journal:
Histopathology
Issue:
Volume 78:Issue 6(2021)
Page Start:
831
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Issue 4 (April 2021)

Authors:
Frontzek, Fabian; Ziepert, Marita; Nickelsen, Maike; Altmann, Bettina; Glass, Bertram; Haenel, Mathias; Truemper, Lorenz; Held, Gerhard; Bentz, Martin; Borchmann, Peter; Dreyling, Martin; Viardot, Andreas; Kroschinsky, Frank P; Metzner, Bernd; Staiger, Annette M; Horn, Heike; Ott, German; Rosenwa...
Journal:
Lancet
Issue:
Volume 8:Issue 4(2021)
Page Start:
e267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗